Bright Minds Biosciences (TSE:DRUG) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bright Minds Biosciences is set to present groundbreaking data on its novel drug BMB-101 at the American Epilepsy Society’s 2024 Annual Meeting. The company focuses on innovative treatments for drug-resistant epilepsy and other CNS disorders, showcasing the potential of BMB-101 in advancing epilepsy management.
For further insights into TSE:DRUG stock, check out TipRanks’ Stock Analysis page.